Outlook Therapeutics, Inc. Common Stock

$0.3708

+0.0207 (+5.91%)

Volume:

1.342M ($497.58K)

#739 Volume #3650 Dollar Volume

Market Capitalization:

$30.80M

#4637 Market Cap

Outlook Therapeutics Price Chart

Outlook Therapeutics Volume Chart

Outlook Therapeutics Market Segments

Regular Trading Hours

-0.0082(-2.16%)

Open	$0.3790
Close	$0.3708
Low	$0.3602
Low Change	-0.0188 (-4.96%)
High	$0.4000
High Change	+0.0210 (+5.54%)
Range	$0.0398
Volume	1.298M
Dollar Volume	$481.22K

Premarket

-0.0105(-2.76%)

Open	$0.3811
Close	$0.3706
Low	$0.3543
Low Change	-0.0268 (-7.03%)
High	$0.3926
High Change	+0.0115 (+3.02%)
Range	$0.0383
Volume	44.163K
Dollar Volume	$16.37K

After Hours Yesterday

+0.0138(+3.88%)

Open	$0.3560
Close	$0.3698
Low	$0.3510
Low Change	-0.0050 (-1.40%)
High	$0.3708
High Change	+0.0148 (+4.16%)
Range	$0.0198
Volume	24.635K
Dollar Volume	$9.11K

Regular Trading Hours Yesterday

-0.0499(-12.48%)

Open	$0.4000
Close	$0.3501
Low	$0.3418
Low Change	-0.0582 (-14.55%)
High	$0.4050
High Change	+0.0050 (+1.25%)
Range	$0.0632
Volume	3.352M
Dollar Volume	$1.17M

Premarket Yesterday

+0.0009(+0.23%)

Open	$0.3941
Close	$0.3950
Low	$0.3941
Low Change	0.0000 (0.00%)
High	$0.4050
High Change	+0.0109 (+2.77%)
Range	$0.0109
Volume	18.568K
Dollar Volume	$7.33K

Outlook Therapeutics Moving Averages

5 Day Moving Average (SMA5)	$0.4075
10 Day Moving Average (SMA10)	$0.4173
20 Day Moving Average (SMA20)	$0.4204
50 Day Moving Average (SMA50)	$0.4680
100 Day Moving Average (SMA100)	$1.0835
200 Day Moving Average (SMA200)	$1.3836

Outlook Therapeutics Statistics

Average Volume (30 Days)	1.27M
P/E Ratio (Current)	-.31
EPS (Current)	-$1.24
Dividend Yield	0.00%
Free Cash Flow	—
Cash Ratio	0.18
Current Ratio	0.35
Quick Ratio	0.28
Debt to Equity	-0.95
Enterprise Value	$60.38M
EV to EBITDA	-1.03
EV to Sales	293.53
Price to Book	-0.84
Price to Cash Flow	—
Price to Free Cash Flow	—
Price to Sales	157.49
Return on Assets	-5.64%
Return on Equity	2.67%

Outlook Therapeutics Stock Splits

There have been 2 stock splits for Outlook Therapeutics (OTLK). The last reverse stock split occured on March 14, 2024 and reduced the outstanding shares at a ratio of 20:1.

Date	Type	Ratio
Mar 14, 2024	Reverse	20:1
Mar 18, 2019	Reverse	8:1

Outlook Therapeutics Dividends

There have been no dividends for Outlook Therapeutics (OTLK).